scholarly journals MINTS The Next Economic Frontier for Investment – A Financial Analysis of the Pharmaceutical Industry

2016 ◽  
Vol 4 (8) ◽  
pp. 132-145
Author(s):  
Joseph Henry Jurkowski ◽  
Dion D Daly
Keyword(s):  
Emerging Economies ◽  
Financial Analysis ◽  
Communicable Disease ◽  
Geographical Location ◽  
Criminal Activity ◽  
Pharmaceutical Products ◽  
Bric Countries ◽  
Religious Issues ◽  
New Frontier ◽  
The World

We have heard a great deal recently of the BRIC countries (Brazil, Russia, India, China), and the PIGS (Portugal, Italy, Greece, Spain) but now the focus seems to be on the MINT countries, (Malaysia, Indonesia, Nigeria, and Turkey) as the leading emerging economies in the world. Rising labor and other costs now have companies looking for new opportunities in rapid growth markets. But not without specific risks that companies must be willing to take. Corruption, rampant communicable disease, drug abuse and criminal activity, religious issues and disagreements are a few of the challenges companies must face in the new frontier. This paper will attempt to look at four pharmaceutical companies in each of the MINT countries to determine their potential profitability as an investment opportunity. This industry is especially unique since these countries have a growing population which will increase the labor force and also create a need for pharmaceutical products. Each of these countries is located in an advantageous geographical location which will provide an advantage in growing their economies. Mexico is next to the U.S. and the rest of Latin America. Indonesia is located in the heart of Southeast Asia with strong ties to China. Turkey has positioned itself to have both Eastern and Western influences. Nigeria is in a prime spot as it ls located in the prime economic powerhouse of a continent, Africa. If they get their acts together, solve their problems of corruption, energy, and infrastructure, these four countries could potentially overtake China as a leading economy of the world.

scholarly journals The situation of women in BRIC countries: a comparative analysis of the (in) effectiveness of public policies for the protection of women and reduction of gender inequality in the four largest emerging economies in the world

2019 ◽  
Vol 5 (1) ◽  
pp. 121-141
Author(s):  
Diva Júlia Sousa Safe Coelho ◽  
Ricardo Spindola Diniz ◽  
Saulo De Oliveira Pinto Coelho
Keyword(s):  
Comparative Analysis ◽  
Gender Inequality ◽  
Emerging Economies ◽  
Comparative Law ◽  
International Context ◽  
Classical View ◽  
Bric Countries ◽  
Explorative Study ◽  
The World ◽  
The Subject

The research consists of a comparative study of the concrete experiences of Russia, China, India and Brazil on the implementation of policies for the protection of women and reduction of gender inequality. From a constitutional perspective of analysis, it seeks to overcome the purely nomological or doctrinal comparison, typical of the classical view of Comparative Law, in favor of an experiences and realities comparison. To achieve this goal, it uses a complex set of data gathered from relevant reports on the subject in the international context, as well as, realizing a explorative study of the existing literature on the subject in each of the countries. As main results, it was verified that the four countries suffer from serious problems regarding the effectiveness of gender equality and the guarantee of women’s dignity, freedom, and respect. However, each country faces specific challenges in dealing with the issue.

Turkey’s foreign policy in perspective: Some regional and national interests

2020 ◽  
Vol 2020 (10-3) ◽  
pp. 82-92
Author(s):  
Gekkaya Funda
Keyword(s):  
Foreign Policy ◽  
Political Ideology ◽  
Geographical Location ◽  
National Interests ◽  
Security Culture ◽  
Center Stage ◽  
External Relations ◽  
The World ◽  
Transit Route ◽  
And Control

The formation of external policy of any country aims at serving the state’s interests. For this matter, many countries seek their way through this by taking into account the potential prospects available to them. The fundamental subtleties and factors that influence a state’s choices of external policy include geographical location, history, security, culture, trade, political ideology, military might, et cetera. Countries often make external contacts based on some regulations and response to unfolding events. Thus, external policy to an extent pertains to the guiding principles outlined to be pursued through state values, decisions and actions taken by the states themselves and their attempt to develop, manage and control the external relations of national societies. In this regard, the Caucasian region has been an important factor in Turkey’s foreign policy. Since these states emerged in the early 1990s, energy has taken a center stage within the region, while Turkey remains a transit route to the world...

Competition Policy for the New Era

2018 ◽  
Keyword(s):  
Developing Countries ◽  
Emerging Economies ◽  
Competition Policy ◽  
Competition Law ◽  
Critical Discussion ◽  
Industrialized Countries ◽  
Collective Wisdom ◽  
Brics Countries ◽  
Law And Policy ◽  
The World

This book presents a new stage in the contributions of the BRICS countries (Brazil, Russia, India, China, and South Africa) to the development of Competition Law and policy. These countries have significant influence in their respective regions and in the world. The changing global environment means greater political and economic role for the BRICS and other emerging countries. BRICS countries are expected to contribute nearly half of all global gross domestic product growth by 2020. For more than a century, the path of Competition Law has been defined by the developed and industrialized countries of the world. Much later, developing countries and emerging economies came on the scene. They experience many of the old competition problems, but they also experience new problems, and experience even the old problems differently. Where are the fora to talk about Competition Law and policy fit for developing and emerging economies? The contributors in this book are well-known academic and practising economists and lawyers from both developed and developing countries. The chapters begin with a brief introduction of the topic, followed by a critical discussion and a conclusion. Accordingly, each chapter is organized around a central argument made by its author(s) in relation to the issue or case study discussed. These arguments are thoughtful, precise, and very different from each another. Each chapter is written to be a valuable freestanding contribution to our collective wisdom. The set of case studies as a whole helps to build a collection of different perspectives on competition policy.

scholarly journals Drivers of Firm’s Value: Panel Data Evidence from Indian Manufacturing Industry

2015 ◽  
Vol 7 (2) ◽  
pp. 1 ◽  
Author(s):  
Ranjit Tiwari ◽  
Brajesh Kumar
Keyword(s):  
Emerging Economies ◽  
Manufacturing Industry ◽  
Developing Economies ◽  
Panel Regression ◽  
Strategic Choices ◽  
Significant Relation ◽  
Value Drivers ◽  
Book Value ◽  
Earnings Per Share ◽  
The World

<p>The purpose of this paper is to classify the value drivers into broad categories and then identify the major drivers of firm’s value for Indian manufacturing industry and also work out the sectorial sensitivity of value drivers. To achieve the objectives of the study we first derive the value driver’s model next we use panel regression with different model specifications to empirically analyse the major drivers of firm’s value. Our study reveals that sales, net margin, book value, dividend per share, beta and earnings per share are the six major financial drivers of value. All the strategic drivers when included in the model have significant relation with value without disturbing the r-square of the model. Thus, it is clear that apart from generic financial drivers, firms need to put more attention on strategic choices they make, because it is the strategic choice that will give firms an edge over others in developing economies like India. Further, we also observe sector specific priorities of the value drivers. This paper provides academicians and practitioners with an overview of the applicability of value drivers for Indian manufacturing industry. Further, the study will fill the gap in literature by adding value drivers’ evidence from one of the fastest growing economies in the world and will benefit researchers in arriving at common consensus for value drivers in emerging economies. </p>

scholarly journals Commodity price pass-through along the pricing chain

2021 ◽  
Author(s):  
Rebeca Jiménez-Rodríguez ◽  
Amalia Morales-Zumaquero
Keyword(s):  
Emerging Economies ◽  
Raw Materials ◽  
Commodity Prices ◽  
Commodity Price ◽  
Emerging Countries ◽  
Consumer Prices ◽  
Advanced Economies ◽  
The World ◽  
Producer Prices ◽  
Pass Through

AbstractThis paper analyses the commodity price pass-through along the pricing chain for the global commodity price index and the indices of its main categories (i.e., agricultural raw materials, food and beverages, energy and metals) in the world, advanced and emerging economies. To do so, the study considers country-by-country vector autoregression models and pool the results by taking weighted means for 18 advanced economies and 19 emerging countries, as well as for the world (defined as the sum of advanced and emerging economies). The results show the following: (i) there is evidence in favour of partial pass-through from commodity prices to producer prices, although the evidence for the pass-through to consumer prices is less evident; (ii) the pass-through in the world seems to be led by both advanced and emerging countries for producer prices and only by advanced economies for consumer prices; (iii) higher prices in the four categories (agricultural raw materials only in the short-run) induce significant higher producer prices in almost all cases, with shocks in the prices of energy and metals showing the largest effects; and (iv) energy prices explain the highest variability of producer and consumer prices.

scholarly journals What's in a Word? Falsified/Counterfeit/Fake Medicines - The Definitions Debate

2017 ◽  
Vol 1 ◽  
pp. maapoc.0000008 ◽  
Author(s):  
Mike Isles
Keyword(s):  
World Wide ◽  
Criminal Activity ◽  
Access To Medicines ◽  
World Region ◽  
The Public ◽  
Counterfeit Medicine ◽  
The World ◽  
Falsified Medicines ◽  
Trademark Protection ◽  
Exact Size

There is a rising tide of criminal activity to manufacture and distribute falsified, counterfeit, or fake medicines. The exact size of this problem is unknown but estimates vary from US$75 billion to US$200 billion per year, and evidence clearly demonstrates it is on the increase. Depending on the world region, infiltration into the legitimate supply chain versus the illegitimate (e.g., the internet) varies greatly. However, what is certain is that the direction of travel by regulatory agents is to develop supply chains that allow access to medicines via the World Wide Web. Within this context, there has been a long-running debate about how to correctly describe the various forms of medicines that are fraudulently or otherwise manufactured and distributed. This article attempts to describe the evolution of the definitions and recommends that a consensus be formed to describe such medicines that reach the public: • Falsified medicine: This being the term used and defined in the Falsified Medicines Directive and which is primarily concerned with public health. • Counterfeit medicine: This is closely associated and legally defined within intellectual property legislation and concentrates on trademark protection. • Fake medicine: This is the term that best serves to communicate with the public to raise awareness about the phenomenon.

Specialty Space: Breast Care Centers

2021 ◽  
pp. 193758672199056
Author(s):  
Diane Guevara
Keyword(s):  
Design Process ◽  
Interior Design ◽  
Care Center ◽  
Geographical Location ◽  
Design Guidelines ◽  
Relevant Evidence ◽  
The World ◽  
Hospital Gowns ◽  
Breast Care ◽  
Color Scheme

As background, breast care centers around the world vary in interior design based on geographical location and the trends of the healthcare design process at the time of construction. However, at the forefront of healthcare interior design is the evidence-based design (EBD) process and the Universal Design (UD) guidelines. The Center for Health Design states that the EBD process differs from the linear design process, in that EBD uses relevant evidence to educate and guide the design decisions. The objective of this study was to support future EBD and UD use in the development of patient areas in breast care center interior design. The methods for this study incorporated an extensive review of the literature, examples of eight breast care centers around the world, observations, an interview, and a staff survey concerning the interior design of a local breast care center. The results revealed that using the EBD process and UD, to develop guidelines for patient areas in breast care centers’ interior design, directors could use guidelines to evaluate existing breast care centers or preconstruction for new breast care centers. This study concluded with design guidelines for patient areas in breast care center interior design. The recommended guidelines targeted the following features: robes (vs. hospital gowns), spa-like atmosphere, monochromatic color scheme, use of wood and stone, private check-in areas, wayfinding, room temperature comfort, seating comfort, seating style choices including bariatric, personal items storage, access to natural light, indirect artificial lighting, living plants, views of nature, flooring comfort, and wheelchair accessibility.

In vitro evaluation of the anti-mycobacterial properties of the extracts of Momordica Charantia

2021 ◽  
Vol 16 (7) ◽  
pp. 15-22
Author(s):  
Paul Giftson ◽  
Jerrine Joseph ◽  
Revathy Kalyanasundaram ◽  
V. Ramesh Kumar ◽  
Wilson Aruni
Keyword(s):  
Medicinal Plants ◽  
Fungal Pathogens ◽  
Communicable Disease ◽  
Antimycobacterial Activity ◽  
Bitter Gourd ◽  
World Population ◽  
Methanol Extracts ◽  
Crude Extracts ◽  
The World

Tuberculosis (TB) is a communicable disease and remains one of the top 10 causes of death worldwide. One fourth of the world population is infected with TB at a risk of developing disease. The increase in the incidence of drug resistant TB around the world urges the need to develop a new candidate to fight against the disease. Plants were considered as the rich source of bioactive components to be used as potential drugs. Medicinal plants are used in pure as well as crude materials for their medicinal properties. Our research aims in identifying the phyto-molecules which have anti- tuberculosis property. Four medicinal plants namely, Acalyphaciliata (Kuppaimeni), Solanumtrilobatum (Thuthuvalai), Momordicacharantia (Bitter Gourd) and Sennaauriculata (Avaram) were chosen to evaluate their antimicrobial activity focusing on anti-tubercular activity. The methanol extracts of the medicinal plants showed significant inhibitory activity against bacterial and fungal pathogens. Sennaauriculata methanol extracts showed activity against S. aureus, E. coli, P. aeruginosa and C. albicans. In the screening of antimycobacterial activity done by LRP assay, among the plant extracts tested, the hexane crude extracts of Momordicacharantia (Bitter Gourd) showed 82.2% and 81.03% of inhibition against M. tuberculosis H37Rv at 500µg/ml and 250µg/ml concentration respectively. Similarly, the methanol crude extracts of Momordicacharantia showed 87.14% and 63.55% of inhibition at 500µg/ml and 250µg/ml concentration respectively.

Icelandic Healthcare System

2020 ◽  
pp. 72-77
Author(s):  
Elena Frolova
Keyword(s):  
Life Expectancy ◽  
Olive Oil ◽  
Healthcare System ◽  
Fruits And Vegetables ◽  
Geographical Location ◽  
Health Index ◽  
Average Life Expectancy ◽  
The World ◽  
Level Of Economic Development ◽  
Restrictive Measures

Today the whole world continues to look at the surrounding reality through the prism of the coronavirus. A few months ago, in our relatively prosperous life without quarantine, the world-famous Bloomberg agency compiled another rating of countries according to the health index, on top of which were Spain and Italy. When compiling this rating, the average life expectancy of the population, the level of economic development, geographical location, prevalence of bad habits, the availability of clean drinking water, etc. were taken into account. The combination of these indicators provides data for the formation of a health index, which in Spain amounted to 92.8, and in Italy - 91.6. It is believed that the main factor contributing to the high health index in these countries is the favorable climate and the ability to keep to the Mediterranean diet, which is based on olive oil, seafood and a large amount of fruits and vegetables. However, as the tragic reality shows, countries with the best organization of the healthcare system in the world were not able to withstand the epidemic. What is the situation in the country that is the third of the top three in the ranking compiled by Bloomberg - Iceland? There is neither a favourable climate, nor olive oil, nor fresh shrimps, and the average temperature in the summer months there is +10°C. Nevertheless, in terms of life expectancy, this country left behind all the Scandinavian countries and came close to Singapore and Japan. And if we talk about the prevalence of coronavirus, then as of early April, as a result of testing of 4.7% of the population 1364 cases were found in the country, and the number of deaths was only 4. A mass examination of citizens, notably free of charge for everyone, immediate tracking of the routes of infection and isolation of the ill allowed the Icelandic authorities to take control of the situation from the very beginning of the epidemic, even without the introduction of strict restrictive measures [1].

Sign in / Sign up

Export Citation Format

Share Document